The Market Reports

Index

1 Lung Disease Therapeutic Drug Market Overview
1.1 Product Overview and Scope of Lung Disease Therapeutic Drug
1.2 Lung Disease Therapeutic Drug Segment by Type
1.2.1 Global Lung Disease Therapeutic Drug Market Value Comparison by Type (2023-2029)
1.2.2 Corticosteroids
1.2.3 Bronchodilator Medications
1.2.4 Mucolytics
1.2.5 Antimicrobial Medications
1.2.6 Others
1.3 Lung Disease Therapeutic Drug Segment by Application
1.3.1 Global Lung Disease Therapeutic Drug Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Lung Disease Therapeutic Drug Market Size Estimates and Forecasts
1.4.1 Global Lung Disease Therapeutic Drug Revenue 2018-2029
1.4.2 Global Lung Disease Therapeutic Drug Sales 2018-2029
1.4.3 Global Lung Disease Therapeutic Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lung Disease Therapeutic Drug Market Competition by Manufacturers
2.1 Global Lung Disease Therapeutic Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Lung Disease Therapeutic Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Lung Disease Therapeutic Drug Average Price by Manufacturers (2018-2023)
2.4 Global Lung Disease Therapeutic Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Lung Disease Therapeutic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lung Disease Therapeutic Drug, Product Type & Application
2.7 Lung Disease Therapeutic Drug Market Competitive Situation and Trends
2.7.1 Lung Disease Therapeutic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lung Disease Therapeutic Drug Players Market Share by Revenue
2.7.3 Global Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lung Disease Therapeutic Drug Retrospective Market Scenario by Region
3.1 Global Lung Disease Therapeutic Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lung Disease Therapeutic Drug Global Lung Disease Therapeutic Drug Sales by Region: 2018-2029
3.2.1 Global Lung Disease Therapeutic Drug Sales by Region: 2018-2023
3.2.2 Global Lung Disease Therapeutic Drug Sales by Region: 2024-2029
3.3 Global Lung Disease Therapeutic Drug Global Lung Disease Therapeutic Drug Revenue by Region: 2018-2029
3.3.1 Global Lung Disease Therapeutic Drug Revenue by Region: 2018-2023
3.3.2 Global Lung Disease Therapeutic Drug Revenue by Region: 2024-2029
3.4 North America Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.4.1 North America Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.4.3 North America Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.5.1 Europe Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.5.3 Europe Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.7.1 Latin America Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.7.3 Latin America Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lung Disease Therapeutic Drug Sales by Type (2018-2029)
4.1.1 Global Lung Disease Therapeutic Drug Sales by Type (2018-2023)
4.1.2 Global Lung Disease Therapeutic Drug Sales by Type (2024-2029)
4.1.3 Global Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
4.2 Global Lung Disease Therapeutic Drug Revenue by Type (2018-2029)
4.2.1 Global Lung Disease Therapeutic Drug Revenue by Type (2018-2023)
4.2.2 Global Lung Disease Therapeutic Drug Revenue by Type (2024-2029)
4.2.3 Global Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
4.3 Global Lung Disease Therapeutic Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lung Disease Therapeutic Drug Sales by Application (2018-2029)
5.1.1 Global Lung Disease Therapeutic Drug Sales by Application (2018-2023)
5.1.2 Global Lung Disease Therapeutic Drug Sales by Application (2024-2029)
5.1.3 Global Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
5.2 Global Lung Disease Therapeutic Drug Revenue by Application (2018-2029)
5.2.1 Global Lung Disease Therapeutic Drug Revenue by Application (2018-2023)
5.2.2 Global Lung Disease Therapeutic Drug Revenue by Application (2024-2029)
5.2.3 Global Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
5.3 Global Lung Disease Therapeutic Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Lung Disease Therapeutic Drug Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Lung Disease Therapeutic Drug Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Ingelheim Lung Disease Therapeutic Drug Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis Lung Disease Therapeutic Drug Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Lung Disease Therapeutic Drug Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Vertex Pharmaceuticals
6.6.1 Vertex Pharmaceuticals Corporation Information
6.6.2 Vertex Pharmaceuticals Description and Business Overview
6.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product Portfolio
6.6.5 Vertex Pharmaceuticals Recent Developments/Updates
6.7 F. Hoffman La Roche
6.6.1 F. Hoffman La Roche Corporation Information
6.6.2 F. Hoffman La Roche Description and Business Overview
6.6.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 F. Hoffman La Roche Lung Disease Therapeutic Drug Product Portfolio
6.7.5 F. Hoffman La Roche Recent Developments/Updates
6.8 Teva Pharmaceuticals
6.8.1 Teva Pharmaceuticals Corporation Information
6.8.2 Teva Pharmaceuticals Description and Business Overview
6.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Drug Product Portfolio
6.8.5 Teva Pharmaceuticals Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cipla Lung Disease Therapeutic Drug Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Fibrogen
6.10.1 Fibrogen Corporation Information
6.10.2 Fibrogen Description and Business Overview
6.10.3 Fibrogen Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Fibrogen Lung Disease Therapeutic Drug Product Portfolio
6.10.5 Fibrogen Recent Developments/Updates
6.11 Liminal Biosciences
6.11.1 Liminal Biosciences Corporation Information
6.11.2 Liminal Biosciences Lung Disease Therapeutic Drug Description and Business Overview
6.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Liminal Biosciences Lung Disease Therapeutic Drug Product Portfolio
6.11.5 Liminal Biosciences Recent Developments/Updates
6.12 PharmAkea Therapeutics
6.12.1 PharmAkea Therapeutics Corporation Information
6.12.2 PharmAkea Therapeutics Lung Disease Therapeutic Drug Description and Business Overview
6.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Drug Product Portfolio
6.12.5 PharmAkea Therapeutics Recent Developments/Updates
6.13 IQVIA
6.13.1 IQVIA Corporation Information
6.13.2 IQVIA Lung Disease Therapeutic Drug Description and Business Overview
6.13.3 IQVIA Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 IQVIA Lung Disease Therapeutic Drug Product Portfolio
6.13.5 IQVIA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lung Disease Therapeutic Drug Industry Chain Analysis
7.2 Lung Disease Therapeutic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lung Disease Therapeutic Drug Production Mode & Process
7.4 Lung Disease Therapeutic Drug Sales and Marketing
7.4.1 Lung Disease Therapeutic Drug Sales Channels
7.4.2 Lung Disease Therapeutic Drug Distributors
7.5 Lung Disease Therapeutic Drug Customers
8 Lung Disease Therapeutic Drug Market Dynamics
8.1 Lung Disease Therapeutic Drug Industry Trends
8.2 Lung Disease Therapeutic Drug Market Drivers
8.3 Lung Disease Therapeutic Drug Market Challenges
8.4 Lung Disease Therapeutic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer